CUL1 and colorectal cancer: Melanoma (17.76%), lung cancer (13.16%), endometrioid carcinoma (8.33%), bone cancer (8.2%), colorectal cancer (7.69%), and pancreatic cancer (7.61%) were among the cancers that had relatively high DNA CUL1 DNA amplification (Figure 2B).